Evaluation of the uses of aspirin, statins and ACEIs/ARBs in a diabetes outpatient population in southern Thailand

Journal of Evaluation in Clinical Practice

Volumn 13, Issue 2, 2007, Pages 221-226

  Pongwecharak, J ^a   Maila Ead, C ^a   Sakulthap, J ^a   Sripanitkulchai, N ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

ACEIs; ARBs; Aspirin; Diabetes; Diabetes outpatient clinic; Statins; Underuse

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ALBUMINURIA; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMMUNITY HOSPITAL; COMPUTER ASSISTED DRUG THERAPY; CONTROLLED STUDY; DRUG USE; DYSLIPIDEMIA; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MEDICAL SOCIETY; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; POPULATION RESEARCH; PRESCRIPTION; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEINURIA; SECONDARY PREVENTION; SEX DIFFERENCE; STROKE; TEACHING HOSPITAL; THAILAND; TRANSIENT ISCHEMIC ATTACK;

ADULT; AGED; AGED, 80 AND OVER; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICAL AUDIT; MIDDLE AGED; OUTPATIENTS; PRESCRIPTIONS, DRUG; THAILAND;

EID: 33947414397     PISSN: 13561294     EISSN: 13652753     Source Type: Journal    
DOI: 10.1111/j.1365-2753.2006.00680.x     Document Type: Article

References (26)

1. King, H., Aubert, R. E. & Herman, W. H. (1998) Global burden of diabetes, 1995-2025: prevalence, numerical estimates and projections. Diabetes Care, 21, 1414-1431.
2. National Health Interview and Examination Survey (NHIES) (1996-1997) Research Institute of Thai Public Health, National Foundation of Public Health. Bangkok: NHIES.
3. Bureau of Policy and Strategy Ministry of Public Health (2003) Public Health Statistics. Available at: http://203.157.19.191.
4. Vichayanrat, A. (ed.) (2003) Textbook of Diabetes Mellitus, 1st edn. Bangkok: The Endocrine Society of Thailand.
5. Suwattee, P., Lynch, J. C. & Pendergrass, M. L. (2003) Quality of care for diabetic patients in a large urban public hospital. Diabetes Care, 26, 563-568.
6. American Diabetes Association (ADA) (2004) Aspirin therapy in diabetes. Diabetes Care, 27, S72-S73.
7. American Diabetes Association (ADA) (2004) Dyslipidemia management in adults with diabetes. Diabetes Care, 27, S68-S71.
8. American Diabetes Association (ADA) (2004) Nephropathy in diabetes. Diabetes Care, 27, S79-S83.
9. Choudhry, N. K. & Avorn, J. (2005) Over-the-counter statins. Annals of Internal Medicine, 142, 910-913.
10. Tonstad, S., Rosvold, E. O., Furu, K. & Skurtveit, S. (2004) Undertreatment and overtreatment with statins: the Oslo Health Study 2000-2001. Journal of Internal Medicine, 255, 494-452.
11. Grant, R. W., Cagliero, E., Sullivan, C. M., et al. (2004) A controlled trial of population management diabetes mellitus: putting evidence into practice (DM-PEP). Diabetes Care, 27, 2299-2305.
12. Toth, E. L., Majumdar, S. R., Guirguis, L. M., Lewanczuck, R. Z., Lee, T. K. & Johnson, J. A. (2004) Compliance with clinical practice guidelines for Type 2 diabetes in rural patients: treatment gaps and opportunities for improvement. Pharmacotherapy, 23, 659-665.
13. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Journal of the American Medical Association, 285, 2486-2497.
14. Jassim Al Khaja, K. A., Sequeira., R. P. & Damanhori, A. H. H. (2005) Evaluation of drug therapy and risk factors in diabetic hypertensive: a study of quality of care provided in diabetic clinics in Bahrain. Journal of Evaluation in Clinical Practice, 11, 121-131.
15. Brown, L. C., Johnson, J. A., Majumdar, S. R., Tsuyuki, R. T. & McAlister, F. A. (2004) Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis. Canadian Medical Association Journal, 171, 1189-1192.
16. Teeling, M., Bennett, K. & Feely, J. (2005) The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002. British Journal of Clinical Phamacology, 59, 227-232.
17. Basit, A., Hydrie, M. Z., Hakeem, R., Ahmedani, M. Y. & Masood, Q. (2004) Frequency of statin use in type 2 diabetics having macrovascular disease - at a Tertiary care hospital of Karachi (Abstract). Journal of Ayub Medical College, Abbottabad, 16, 60-64.
18. Lee, J. D., Morrissey, J. R., Mikhailidis, D. P. & Patel, V. (2005) CARDS on the table: should everybody with type2 diabetes take a statin? Current Medical Research and Opinion, 21, 357-361.
19. Nguyen, K. X., Marinac, J. S. & Sun, C. (2005) Aspirin for primary prevention in patients with diabetes mellitus. Family Medicine, 37, 112-117.
20. Krein, S. L., Pogach, V. S., Hogan, M. M. & Kerr, E. A. (2002) Aspirin use and counselling about aspirin among patients with diabetes. Diabetes Care, 25, 965-970.
21. Faragaon, J. J., Waite, N. M., Hobson, E. H., Seoldo, N., VanAmburgh, J. A. & Migden, H. (2003) Improving aspirin prophylaxis in a primary care diabetic population. Pharmacotherapy, 23, 73-79.
22. Klinke, J. A., Johnson, J. A., Guirguis, L. M., Toth, E. L., Lee, T. K., Lewanczuck., R. Z. & Majumdar, S. R. (2004) Underuse of aspirin in type 2 diabetes mellitus: prevalence and correlates of therapy in rural Canada. Clinical Therapeutics, 26, 439-446.
23. Persell, S. D. & Baker, D. W. (2004) Aspirin use among adults with diabetes. Recent trends and emerging sex disparities. Archives of Internal Medicine, 164, 2492-2499.
24. Cull, C. A., Neil, H. A. W. & Holman, R. R. (2004) Changing aspirin use in patients type 2 diabetes in the UKPDS. Diabetic Medicine, 21, 1368-1371.
25. Boero, R., Prodi, E., Elia, F., Porta, L., Martelli, S., Ferraro, L. & Quarello, F. (2003) How well are hypertension and albuminuria treated in type II diabetes patients? Journal of Human Hypertension, 17, 413-418.
26. Greenfield, S., Bryan, S., Gill, P., Gutridge, K. & Marshall, T. (2005) Factors influencing clinicians' decisions to prescribe medication to prevent coronary heart disease. Journal of Clinical Pharmacy and Therapeutics, 30, 77-84.